Stephen P. Ewald, an officer of Medpace Holdings, Inc., filed a Form 144 notice of proposed sale on October 29, 2026, covering 1,245 shares of common stock acquired through a stock option exercise.

Key Highlights

  • Seller: Stephen P. Ewald, identified as an officer of Medpace Holdings, Inc.
  • Shares proposed for sale: 1,245 shares of common stock, with an aggregate market value of $859,050.00.
  • Acquisition method: Shares were acquired via stock option exercise from the issuer on October 27, 2025, with cash payment on the same date.
  • Approximate date of sale: October 29, 2026, through Fidelity Brokerage Services LLC.
  • Shares outstanding: The filing lists 27,971,686 shares of common stock outstanding.
  • Prior sales: The filing reports nothing to report for securities sold during the past three months.

Ewald's Proposed Rule 144 Sale of Medpace Common Stock

According to the filing, Stephen P. Ewald, an officer of Medpace Holdings, Inc. (NASDAQ:MEDP), submitted a Form 144 notice of proposed sale to the U.S. Securities and Exchange Commission on October 29, 2026. The notice covers 1,245 shares of Medpace common stock, with an aggregate market value listed as $859,050.00. The proposed sale is to be executed through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, Rhode Island 02917.

The filing discloses that the 1,245 shares were acquired on October 27, 2025, through a stock option exercise from the issuer, with full cash payment made on that same date. The notice indicates the approximate date of sale as October 29, 2026, on the NASDAQ exchange. The filing further notes that no securities of Medpace Holdings were sold by Ewald during the past three months, as indicated by the "Nothing to Report" designation in the relevant section.

The Form 144 was signed by Wade Moss as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Stephen P. Ewald. By signing, the filer represented, as stated in the filing, that Ewald "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed."

What Was Disclosed

Medpace Holdings officer Stephen P. Ewald filed a Form 144 notice proposing to sell 1,245 shares of common stock acquired via stock option exercise on October 27, 2025. The aggregate market value of the proposed sale is listed as $859,050.00, with no prior sales reported in the past three months.